GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Book Value per Share

LTR Pharma (ASX:LTP) Book Value per Share : A$0.05 (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Book Value per Share?

LTR Pharma's book value per share for the quarter that ended in Jun. 2023 was A$0.05.

During the past 12 months, LTR Pharma's average Book Value Per Share Growth Rate was 315.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

LTR Pharma's current price is A$0.64. Its book value per share for the quarter that ended in Jun. 2023 was A$0.05. Hence, today's PB Ratio of LTR Pharma is 11.85.

During the past 3 years, the highest P/B Ratio of LTR Pharma was 11.85. The lowest was 0.00. And the median was 0.00.


LTR Pharma Book Value per Share Historical Data

The historical data trend for LTR Pharma's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Book Value per Share Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23
Book Value per Share
- 0.01 0.05

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23
Book Value per Share - 0.01 0.05

Competitive Comparison of LTR Pharma's Book Value per Share

For the Biotechnology subindustry, LTR Pharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LTR Pharma's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LTR Pharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where LTR Pharma's PB Ratio falls into.



LTR Pharma Book Value per Share Calculation

LTR Pharma's Book Value Per Share for the fiscal year that ended in Jun. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(7.49-0.00)/139.42
=0.05

LTR Pharma's Book Value Per Share for the quarter that ended in Jun. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(7.49-0.00)/139.42
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


LTR Pharma  (ASX:LTP) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


LTR Pharma Book Value per Share Related Terms

Thank you for viewing the detailed overview of LTR Pharma's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


LTR Pharma (ASX:LTP) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines